Bioconvergence

Celesta Capital is a global deep tech venture capital firm based in Silicon Valley, investing in leading-edge hardware and software technologies. Their investments focus on companies enabling mass adoption of emerging technologies, improving health outcomes, and transforming large industries. Celesta prides itself on being active investors and advisors, adding value to their portfolio companies.

Pitango is a venture capital firm with three dedicated funds: First, Growth, and HealthTech. They partner with exceptional founding teams, investing in companies from stealth mode to maturity. Pitango has invested in over 250 companies and seen more than 85 go public or be acquired.